Loading publications…
The last 5 uploaded publications
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial
Azfar Zaman, Robbert J. de Winter, Norihiro Kogame, Chun Chin Chang, Rodrigo Modolo, Ernest Spitzer, Pim A.L. Tonino, Sjoerd H. Hofma, Aleksander Żurakowski, Pieter C. Smits, Janusz Prokopczuk, Raúl Moreno, Anirban Choudhury, Ivo Petrov, Ángel Cequier, Neville Kukreja, Angela Hoye, Andrés Íñiguez, Imre Ungi, Antonio Serra, Robert Gil, Simon Walsh, Gincho Tonev, Anthony Mathur, Béla Merkely, Antonio Colombo, Sander Ijsselmuiden, Osama Soliman, Upendra Kaul, Yoshinobu Onuma, Patrick W. Serruys (2019). Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial. The Lancet, 393(10175), pp. 987-997, DOI: 10.1016/s0140-6736(18)32467-x.
Article146 days agoQuantification of the minimal luminal cross-sectional area after coronary stenting by two-and three-dimensional intravascular ultrasound versus edge detection and videodensitometry
Clemens von Birgelen, Michael J.B. Kutryk, Robert Gil, Yukio Ozaki, Carlo Di Mario, Jos R.T.C. Roelandt, Pim J. de Feyter, Patrick W. Serruys (1996). Quantification of the minimal luminal cross-sectional area after coronary stenting by two-and three-dimensional intravascular ultrasound versus edge detection and videodensitometry. The American Journal of Cardiology, 78(5), pp. 520-525, DOI: 10.1016/s0002-9149(96)00356-6.
Article146 days agoSlope of the instantaneous hyperemic diastolic coronary flow velocity-pressure relation. A new index for assessment of the physiological significance of coronary stenosis in humans.
Carlo Di Mario, Rob Krams, Robert Gil, Patrick W. Serruys (1994). Slope of the instantaneous hyperemic diastolic coronary flow velocity-pressure relation. A new index for assessment of the physiological significance of coronary stenosis in humans.. Circulation, 90(3), pp. 1215-1224, DOI: 10.1161/01.cir.90.3.1215.
Article146 days agoTicagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI
Marco Valgimigli, Roxana Mehran, Anna Franzone, Bruno R. da Costa, Usman Baber, Raffaele Piccolo, Eugène McFadden, Pascal Vranckx, Dominick J. Angiolillo, Sergio Leonardi, Davide Cao, George Dangas, Shamir R. Mehta, Patrick W. Serruys, C. Michael Gibson, Philippe Gabríel Steg, Samin K. Sharma, Christian W. Hamm, Richard Shlofmitz, Christoph Liebetrau, Carlo Briguori, Luc Janssens, Kurt Huber, Maurizio Ferrario, Vijay Kunadian, David J. Cohen, Aleksander Żurakowski, Keith G. Oldroyd, Yaling Han, Dariuz Dudek, Samantha Sartori, Brian Kirkham, Javier Escaned, Dik Heg, Stephan Windecker, Stuart J. Pocock, Peter Jüni, Marco Valgimigli, Roxana Mehran, Stephan Windecker, Pascal Vranckx, Patrick W. Serruys, Philippe Gabríel Steg, Christian W. Hamm, Usman Baber, Dominick J. Angiolillo, David J. Cohen, George Dangas, Shamir R. Mehta, Michael C. Gibson, Adnan Kastrati, Mitchel Krucoff, Magnus Öhman, Paul A. Gurbel, Timothy D. Henry, David J. Moliterno, Samin K. Sharma, Stuart J. Pocock, Peter Jüni, Bruno R. da Costa, Brian Kirkham, Samantha Sartori, Dik Heg, Eugène McFadden, Sergio Leonardi, Raffaele Piccolo, Anna Franzone, Steven O. Marx, Bruce Darrow, Nicola Corvaja, Douglas DeStefano, Newsha Ghodsi, Jose Meller, Theresa Franklin-Bond, Jin Young, Zaha Waseem, Peter Jüni, Bruno R. da Costa, Brian Kirkham, Kurt Huber, Giora Weisz, Ran Kornowski, Vijay Kunadian, Keith G. Oldroyd, Yaling Han, Upendra Kaul, Bernhard Witzenbichler, Vladimír Džavík, Robert Gil, Dariuz Dudek, Gennaro Sardella, Javier Escaned, Richard Shlofmitz, Carlo Briguori, Edouard Benit, Christoph Liebetrau, Luc Janssens, Maurizio Ferrario, Aleksander Żurakowski, Roberto Diletti (2021). Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 14(4), pp. 444-456, DOI: 10.1016/j.jcin.2020.11.046.
Article146 days agoRegular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial
Robert Gil, Jacek Bil, Maik J. Grundeken, Adam Witkowski, Luis Iñigo Garcia, Dobrin Vassilev, Tomasz Pawłowski, Radosław Formuszewicz, Sławomir Dobrzycki, Joanna J. Wykrzykowska, Patrick W. Serruys (2016). Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial. EuroIntervention, 12(11), pp. e1404-e1412, DOI: 10.4244/eijy15m11_11.
Article146 days ago